Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment

• Status: Terminated
• Trial end date: 2019-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the effectiveness of the rotigotine transdermal patch in reducing anxiety in people with Parkinson's disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Johns Hopkins University
• Collaborator: National Institute on Aging (NIA)
• Treatments: N 0437; Rotigotine

Criteria

Inclusion Criteria:

• Diagnosis of Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 Anxiety Disorder

• Stable medical history and general health

• On stable anti-parkinsonian therapy for 2 weeks before enrollment

Exclusion Criteria:

• Unstable medical disease of comorbid psychiatric disease

• Dementia

• Subjects with less than one year duration of Parkinson's

• Current treatment with a dopamine agonist